Some noteworthy, newly published congressional hearing volumes on intelligence policy and related topics include the following (mostly pdf).
“Attorney General Guidelines for FBI Criminal Investigations, National Security Investigations, and the Collection of Foreign Intelligence,” Senate Intelligence Committee, September 23, 2008.
“Nomination of Michael Leiter to be Director, National Counterterrorism Center,” Senate Intelligence Committee, May 6, 2008.
“U.S. Interrogation Policy and Executive Order 13440,” Senate Intelligence Committee, September 25, 2007.
“Fixing the Homeland Security Information Network: Finding the Way Forward for Better Information Sharing,” House Homeland Security Committee, May 10, 2007.
“Budget Request on Unmanned Aerial Vehicles (UAV) and Intelligence, Surveillance, and Reconnaissance (ISR) Capabilities,” House Armed Services Committee, April 19, 2007.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.